1/ 🧵Excited to share our latest study published in Nature Cancer co-led with amazing co-first authors and friends Tejas Jammihal and Chris Labaki under the exceptional mentorship of Toni Choueiri, MD David Braun Sachet Ashok Shukla nature.com/articles/s4301…

The latest collaboration led by the KaelinLab and #WuLab with David Braun, #SteveCarr, #DerinKeskin Eli Van Allen Dana-Farber Lank Center for Genitourinary Oncology Harvard Medical School Massachusetts Institute of Technology (MIT) DF/HCC in Cell: HIF-2, ERV, T cells, HLA, renal cell carcinoma, et al…. sciencedirect.com/science/articl…

🚀Excited to share our new paper, now published in Nature Communications! ✨ We present BEANIE, a nonparametric method that reduces false positives when analyzing differential gene signature expression in multi-patient clinical scRNA-seq cohorts Eli Van Allen 🧪🧵nature.com/articles/s4146…

PGY-1 Renee Maria Saliby plans to pursue a fellowship in hematology-oncology. "I'm especially drawn to genitourinary malignancies, particularly kidney cancer—a disease that challenges our understanding of both immunology & oncology." More on her below ⬇️ medicine.yale.edu/internal-medic…

Thank you Congresswoman Ayanna Pressley & Bayley Connors Legislative Assistant for supporting Kidney Cancer Research. It was great talking with you today. We appreciate your continued support of Kidney Cancer Funding.  Dana-Farber Dana-Farber Lank Center for Genitourinary Oncology Toni Choueiri, MD KidneyCAN Clara Steiner Eddy Saad

Welcome to our BIDMC IM Residency 2025-26 Intern Class! This exceptional #Match2025 group comes from 46 different medical schools across the country and brings expertise in global health, medical education, QI, research, & more. Can't wait for you to join us BIDMC this summer! 🌟

Proud of you Eddy Saad ! Thank you BIDMC IM Residency ! Dana-Farber Lank Center for Genitourinary Oncology Dana-Farber Eli Van Allen

Incredibly honored and thrilled to have matched at my top choice BIDMC IM Residency! Beyond grateful to my amazing mentors, friends, and family who supported me every step of the way Toni Choueiri, MD Eli Van Allen David Braun Sasha Gusev Maxine Sun

There are no words to express my gratitude for your mentorship and leadership Dr. Pal! For making all these impossibles possible and for helping me reach what once felt like “unreachable stars.” I’ll carry your mentorship every step of the way. Excited for the road ahead at

Congratulations to Lank Center postdoctoral fellows Marc Machaalani, MD and Eddy Saad on receiving Conquer Cancer, the ASCO Foundation Merit Awards for the upcoming ASCO Annual Meeting! conquer.org/sites/default/…

We are looking for an associate research scientist and lab manager for our translational cancer immunology lab at Yale. Please email ([email protected]) or DM me to apply. Full information about the job and the requirements can be found here: jobrxiv.org/job/yale-schoo… Pls RT!

Hard to describe how big of a moment that was! Congrats Dr Renee Maria Saliby for a brilliant ASCO presentation! You make us all proud! And kudos to the whole team behind this work Marc Machaalani Carolina Alves Costa Silva, MD, PhD. It truly takes a village!

The Dana-Farber Lank Center for Genitourinary Oncology (part of it) #WCRM ASCO #ASCO25

.Toni Choueiri, MD takes the stage to present data from the phase 1 ARC-20 trial that shows that the combination of HIF2 inhibitor casdatifan plus cabo has promising clinical activity (cORR 46%) and an acceptable safety profile in pretreated pts w/ mRCC. #ASCO25 ASCO OncoAlert

🌟Great presentation by Chadi Hage Chehade at #ASCO25!! Utilization and timing of NGS in pts w/ 5 most common cancers in the US👉Many pts either don’t receive NGS or have the first NGS very late 👇ASCO OncoAlert Neeraj Agarwal, MD, FASCO Umang Swami Flatiron Health UroToday.com

👉🏻 Our very own Chadi Hage Chehade presenting ASCO a real-world study showing most patients do not undergo NGS testing, and a substantial proportion receive it only near end of life—limiting its clinical utility and impact on treatment decisions. #ASCO25 GU Cancer Research Program @HuntsmanCancer Neeraj Agarwal, MD, FASCO

Hot topic! Marc Machaalani fantastic IM applicant this upcoming cycle presents data on KIM-1 in JR101 #ASCO25 OncoAlert

4 pictures aren’t enough to thank everyone who made this moment possible Sharing an ASCO oral with my co-mentor David Braun and other giants in the field during intern year was surreal Grateful for my Dana-Farber Lank Center for Genitourinary Oncology family, the 💩team, and the one and only Toni Choueiri, MD More

Chromophobe renal cell carcinoma is difficult to treat - Research in Journal of Clinical Oncology provides better understanding of this rare kidney cancer, potential treatment pathways & immunotherapy strategies. Dana-Farber Lank Center for Genitourinary Oncology Eddy Saad Chris Labaki BIDMC ➡️ bit.ly/3IhLT8d

Come join us Memorial Sloan Kettering Cancer Center! You’ll work with Ed Reznik and I on really cool science Please help spread the word Toni Choueiri, MD David Braun Srinivas Viswanathan Eli Van Allen OncoAlert Chris Labaki Renee Maria Saliby Eddy Saad